Send to a Friend Share

Oncothyreon (ONTY) Sees Activity Ahead of BIO CEO & Investor Conference

February 13, 2012 3:37 PM EST
ONTY Hot Sheet
Overall Analyst Rating:
    BUY (Up Up)
Oncothyreon, Inc. (Nasdaq: ONTY) is making a strong afternoon move Monday ahead of the 14th BIO CEO & Investor Conference tomorrow. CEO Robert Kirkman, M.D., will be making a presentations at the event at 2:30pm EST in New York.

Shares are up 6 percent on the session, hitting an intraday high of $9.13 per share.


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Insiders' Blog, Momentum Movers

Add Your Comment





Follow StreetInsider.com On Twitter